Retraction
miR-302e Suppresses Glioma Progression by Targeting VEGFA
Paper Information
Record ID:
27171
Author(s):
Publication Date:
October 30, 2020
Retraction Date:
March 19, 2021
(4.7 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (3)
3
Total Citations2
Post-Retraction(66.7%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
1
After 2+ years
1168
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
MBNL3 Acts as a Target of miR-302e to Facilitate Cell Proliferation, Invasion and Angiogenesis of Gastric Adenocarcinoma via AKT/VEGFA Pathway
Weiping Tang, Can Huang, Bing‐Hua Jiang et al. (5 authors)
Journal of Microbiology and Biotechnology
Open Access
Published: May 2024
1 citation
1 citation
1168 days after retraction
EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR
Xiaoli Li, Chengmou Wang, Guanghui Chen et al. (6 authors)
Metabolic Brain Disease
Published: Jan 2022
18 citations
18 citations
304 days after retraction
Quick Stats
Total Citations:
3
Years Since Retraction:
4.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025